| 1 | FDA has traditionally viewed blending of out-of-spec batches with material that is in specification as an act of adulteration, disguising a defect in a batch by blending it with another batch. |
Copyright © Purple Culture Co., Ltd. 2001 - 2026. All right reserved.
